Table 2.
Comparison of the influencing factors in male diabetic and non-diabetic patients with complications of thyroid nodules
| Influencing factors | Diabetic patients | Non-diabetic patients | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Non-thyroid nodule patients | Thyroid nodule patients | P | Non-thyroid nodule patients | Thyroid nodule patients | P | |
| 25-hydroxyvitamin D | 36.88 ± 6.73 | 38.69 ± 13.39 | 0.8075 | 41.72 ± 12.52 | 43.23 ± 12 | 0.3115 |
| LH | 5.33 ± 3.01 | 10.19 ± 6.81 | 0.2106 | 5.55 ± 3.08 | 6.84 ± 4.86 | 0.0062 |
| FSH | 6.78 ± 3.66 | 19.6 ± 17.58 | 0.0826 | 9.19 ± 5.88 | 11.44 ± 10.56 | 0.0208 |
| Testosterone | 13.38 ± 2.51 | 19.29 ± 9.26 | 0.2477 | 16.13 ± 5.68 | 16.49 ± 5.42 | 0.5943 |
| Estradiol | 170.43 ± 75.57 | 98.6 ± 27.5 | 0.1519 | 103.88 ± 38.07 | 112.15 ± 45.44 | 0.0982 |
| TSH | 2.14 ± 0.27 | 1.57 ± 0.84 | 0.2242 | 2.49 ± 1.96 | 2.04 ± 1.13 | 0.0295 |
| Thyroxine | 107.7 ± 16.64 | 121.55 ± 23.67 | 0.3240 | 100.18 ± 18.83 | 107.08 ± 22.01 | 0.0070 |
| T3 | 1.48 ± 0.14 | 1.31 ± 0.26 | 0.2648 | 1.43 ± 0.21 | 1.43 ± 0.24 | 0.9954 |
| Creatinine | 71.75 ± 8.46 | 101.25 ± 67.95 | 0.2636 | 75.33 ± 9.29 | 75.48 ± 9.8 | 0.9036 |
| GOT | 33.25 ± 14.36 | 36.13 ± 14.54 | 0.7526 | 31.04 ± 14.99 | 28.04 ± 13.46 | 0.0808 |
| GPT | 55 ± 37.9 | 33.38 ± 19.37 | 0.2096 | 29.68 ± 25.18 | 25.92 ± 17.46 | 0.1739 |
| Insulin | 39.33 ± 8.1 | 42.1 ± 31.06 | 0.8181 | 45.66 ± 48.21 | 34.46 ± 27.24 | 0.0285 |